Recent developments in the treatment of adult atopic dermatitis.

about

Mast cells are required for full expression of allergen/SEB-induced skin inflammation.Analysis of the Potential Topical Anti-Inflammatory Activity of Averrhoa carambola L. in Mice.Relationship between levels of IFNγ, TNFα, and TGFβ and pruritus in sulfur mustard-exposed veterans.

P2860

Q37315900-477C1005-C751-4038-B641-CC9886FC004C Q41882226-CB97EC89-E56C-4917-8E03-FA37478E4584 Q45329926-6C0091DA-003B-4E23-A532-4F787D2FC824

P2860

Recent developments in the treatment of adult atopic dermatitis.

Item

http://www.wikidata.org/entity/Q36459429

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Recent developments in the treatment of adult atopic dermatitis.

@ast

Recent developments in the treatment of adult atopic dermatitis.

@en

type

Item

label

Recent developments in the treatment of adult atopic dermatitis.

@ast

Recent developments in the treatment of adult atopic dermatitis.

@en

prefLabel

Recent developments in the treatment of adult atopic dermatitis.

@ast

Recent developments in the treatment of adult atopic dermatitis.

@en

P1476

Recent developments in the treatment of adult atopic dermatitis.

@en

P2093

Ross StC Barnetson

http://www.w3.org/2001/XMLSchema#string

Vernon S C Pua

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.

The treatment of atopic dermatitis with adjunctive high-dose intravenous immunoglobulin: a report of three patients and review of the literature.

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

Epidemiology of atopic dermatitis.

A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders.

Omalizumab treatment downregulates dendritic cell FcepsilonRI expression.

Leukotriene receptor antagonists--a novel therapeutic approach in atopic dermatitis?

Intravenous immune globulin (i.v.IG) therapy in steroid-resistant atopic dermatitis

Immunomodulatory action of intravenous immunoglobulin.

P304

84-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1111/J.1440-0960.2006.00237.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7142799

http://www.w3.org/2001/XMLSchema#string

P698

16637800

http://www.w3.org/2001/XMLSchema#string

Recent developments in the treatment of adult atopic dermatitis.

about

P2860

P2860

Recent developments in the treatment of adult atopic dermatitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698